Amrize CTO granted 4,257 ordinary shares

Amrize Ltd reported that Chief Technology Officer Roald Brouwer acquired 4,257 ordinary shares on a grant or award basis at a stated price of $0.00 per share.

Rhea-AI Filing Summary

Amrize Ltd reported that Chief Technology Officer Roald Brouwer acquired 4,257 ordinary shares on a grant or award basis at a stated price of $0.00 per share. After this settlement, his directly held stake totals 13,257 ordinary shares.

The new shares reflect settlement of performance stock units that originated from Holcim Ltd equity incentives, which were converted in connection with the June 23, 2025 spin-off of Amrize from Holcim. These units vested based on the performance of Holcim and Amrize over the period from January 1, 2023 through December 31, 2025.

Insider Trade Summary

Grant/Award: 4,257 shares

Grant/Award 1 txn

Insider Brouwer Roald

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	4,257	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 13,257 shares (Direct)

Footnotes (1)

1. F1. Represents settlement of an award of performance stock units of Amrize Ltd ("Amrize") into Amrize ordinary shares. The performance stock units that were settled resulted from the conversion of certain equity incentive awards previously granted by Holcim Ltd ("Holcim") and converted in connection with the consummation on June 23, 2025 of the distribution of all of the ordinary shares of Amrize by Holcim to holders of Holcim ordinary shares on a pro rata basis (the "Spin-Off"). Such performance stock units vested based on the performance of Holcim and Amrize for the period from January 1, 2023 through December 31, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Amrize (AMRZ) report for Roald Brouwer?

Amrize reported that Chief Technology Officer Roald Brouwer acquired 4,257 ordinary shares through a grant or award. The shares came from the settlement of performance stock units linked to prior Holcim Ltd equity incentives converted at the Amrize spin-off.

How many Amrize (AMRZ) shares does Roald Brouwer own after this Form 4?

After this transaction, Roald Brouwer directly holds 13,257 Amrize ordinary shares. This total includes the 4,257 shares received from settling performance stock units that vested based on Holcim and Amrize performance from January 1, 2023 through December 31, 2025.

What was the price per share for Roald Brouwer’s Amrize (AMRZ) grant?

The 4,257 Amrize ordinary shares reported for Roald Brouwer had a stated price per share of $0.00. They reflect the settlement of performance stock units rather than an open-market purchase, so no cash consideration per share is shown in the filing.

How is the Amrize (AMRZ) grant to Roald Brouwer connected to Holcim Ltd?

The award represents performance stock units that originated from Holcim Ltd equity incentive grants and were converted into Amrize units at the June 23, 2025 spin-off. Vesting depended on the performance of both Holcim and Amrize from January 1, 2023 to December 31, 2025.

What is the transaction code and type in this Amrize (AMRZ) Form 4?

The filing uses transaction code “A,” indicating a grant, award, or other acquisition of non-derivative securities. It records settlement of performance stock units into 4,257 Amrize ordinary shares for Chief Technology Officer Roald Brouwer on February 27, 2026, classified as a direct holding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 10:57 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brouwer Roald

(Last) (First) (Middle)

GRAFENAUWEG 8

(Street)

ZUG V8 6300

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/27/2026		A(1)		4,257	A	$0	13,257	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents settlement of an award of performance stock units of Amrize Ltd ("Amrize") into Amrize ordinary shares. The performance stock units that were settled resulted from the conversion of certain equity incentive awards previously granted by Holcim Ltd ("Holcim") and converted in connection with the consummation on June 23, 2025 of the distribution of all of the ordinary shares of Amrize by Holcim to holders of Holcim ordinary shares on a pro rata basis (the "Spin-Off"). Such performance stock units vested based on the performance of Holcim and Amrize for the period from January 1, 2023 through December 31, 2025.

	Hans Weinburger, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.